ArticleClinical and experimental nephrology2017

Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.

Kota Takahashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.